PSMA PET finds more cancer than Axumin
A PSMA PET scan (Ga-68-PSMA-11) detected more sites of cancer than an Axumin PET scan in the same recurrent patients. This prospective clinical trial was conducted among 50 men at UCLA in 2018. All men had post-prostatectomy PSA from 0.2- 2.0 ng/ml. The Calais et al. findings are summarized in the following table: Ga-68-PSMA-11 Axumin Detected - % of patients 56%...Read More